The addition of Monjuvi to standard-of-care therapy reduced the risk of disease progression, relapse, or death in patients ...
Imfinzi reduced risk of death by 27% and reduced disease progression by 24% compared to patients receiving a placebo. 2. In ...
Investigating the effects of home-based rehabilitation after intensive inpatient rehabilitation on motor function, activities ...
In this randomized clinical trial (RCT) comparing two forms of clinical decision support (CDS) prevention, interruptive CDS ...
In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...
Tumor Treating Fields therapy demonstrates increased overall survival in patients with unresectable pancreatic cancer. The ...
In this prospective cohort, there was a significantly increased risk of developing cardiovascular disease (CVD) in the ...
High volume-rate echocardiography may be capable of assessing cardiac function in a single heartbeat
High volume-rate echocardiography for simultaneous imaging of electromechanical activation and cardiac strain of the whole heart in a single heartbeat in humans 1. Non-invasive high volume-rate ...
1. Local progression-free survival at 3 years was 84.3% in the SBRT group vs 67.3% in the RFA group, with HR 0.45 (significant). 2. HR for progression-free survival (HR 0.76) and overall survival (HR ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback